- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02243072
Home-Based Interventions for Adolescents With Type 1 Diabetes (R34)
Translating Home-Based Interventions for Adolescents With Poorly Controlled TID
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The proposed study is a planning grant in which MST will be adapted for delivery by community health workers and will be conducted in collaboration with CHASS, a community agency providing health care to underserved residents of Detroit with diabetes. The new intervention, Fit Families (FF), will be tested in a pilot randomized controlled trial in order to evaluate FF feasibility, finalize outcome measures, estimate intervention effect sizes on health outcomes (i.e., youth adherence, glycemic control, quality of life) and determine potential cost savings associated with reduced hospital admissions. These steps will allow for finalization of intervention content and other trial parameters in preparation for a larger R18 dissemination trial.
The design for the proposed study is a randomized, controlled trial using a sample of 60 adolescents. Half will be randomly assigned to the treatment intervention, Fit Families plus standard medical care, and the other half will be assigned to standard medical care alone. Families who are randomized to FF receive intensive, home-based family therapy delivered by a community health worker (CHW) for approximately six months.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Michigan
-
Detroit, Michigan, United States, 48201
- Children's Hospital of Michigan
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- a current hemoglobin A1c(HbA1c) of >9.0%
- an average HbA1c of >9.0% during the past year
- reside in the metro Detroit tri-county area
- diagnosed with Type 1 diabetes for at least one year
- aged 10-17
- patient of Children's Hospital of Michigan Diabetes Clinic
Exclusion Criteria:
- severe mental impairment/thought disorder
- Active suicidality
- Active homicidality
- Diabetes secondary to another comorbid medical condition and/or medical management differing substantially from that of most children with diabetes.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Fit Familes plus Standard Medical Care
Participants will receive the intervention Fit Families plus Standard Medical Care which is an adaptation of Multisystemic Therapy for Type 1 Diabetes delivered by Community Health Workers (CHWs) in addition to standard medical care.
|
Adolescents will receive the Fit Families plus Standard Medical Care which consists of twice weekly home-based, family psychotherapy from a CHW for 6 months
|
|
No Intervention: Standard Medical Care
Standard medical care is provided at Children's Hospital of Michigan consistent with the standards for the care of children with T1D outlined by the American Diabetes Association.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Metabolic Control: Hemoglobin A1c (HbA1c)
Time Frame: Change from Baseline at 7 months, Change from Baseline at 9 months
|
retrospective measure of blood glucose control, encompasses the previous 2-3 months
|
Change from Baseline at 7 months, Change from Baseline at 9 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
DKA admissions and emergency room (ER) Visits: hospital information systems data extraction, Service Utilization Questionnaire (SUQ)
Time Frame: Change from Baseline at 7 months, Change from Baseline at 9 months
|
The number of patient visits to acute care settings represents a significant health care cost in this high-risk population.
|
Change from Baseline at 7 months, Change from Baseline at 9 months
|
|
Quality of life
Time Frame: Change from Baseline at 7 months, Change from Baseline at 9 months
|
44 scale item designed to tap life satisfaction, diabetes impact and diabetes related worries in adolescents.
|
Change from Baseline at 7 months, Change from Baseline at 9 months
|
|
Regimen Adherence: Diabetes Management Scale (DMS), Glucose Meter Downloads
Time Frame: Change from Baseline at 7 months, Change from Baseline at 9 months
|
The DMS assesses a broad range of management behaviors, such as insulin management, dietary management, blood glucose monitoring, symptom response, and parent assistance/supervision.
Glucose meters only assess blood glucose monitoring, but are empirically linked to metabolic control
|
Change from Baseline at 7 months, Change from Baseline at 9 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Deborah A Ellis, Ph.D, Wayne State University
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1R34DK102091-01 (U.S. NIH Grant/Contract)
- R34DK102091 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 1 Diabetes
-
COUR Pharmaceutical Development Company, Inc.RecruitingType 1 Diabetes | Type 1 Diabetes Mellitus | T1DM | T1D | Type 1 Diabetes in Adolescence | Type 1 Diabetes in Children | Type 1 Diabetes Patients | Type 1 Diabetes Mellitis | T1DM - Type 1 Diabetes Mellitus | Type 1 Diabetes (Juvenile Onset)United States
-
Lund UniversityEnrolling by invitationType 1 Diabetes Mellitus | Stage 2 Type 1 Diabetes | Stage 1 Type 1 Diabetes | Stage 3 Type 1 DiabetesSweden
-
Immunocore LtdNot yet recruitingType 1 Diabetes | Diabetes Type 1 | Type 1 Diabetes (T1D)
-
Sultan Qaboos UniversityUniversity of Mosul; University of Child Health Sciences and Children's Hospital...Not yet recruitingType 1 Diabetes Mellitus | T1DM | Type 1 Diabetes Mellitus (T1DM) | T1DM - Type 1 Diabetes Mellitus
-
GentiBio, IncRecruitingType 1 Diabetes Mellitus | Type 1 Diabetes (T1D)United States
-
Stanford UniversityUniversity College Dublin; The Leona M. and Harry B. Helmsley Charitable TrustNot yet recruitingType 1 Diabetes (T1D) | Type 1 Diabetes Mellitus (T1DM) | Exercise Physiology | Type 1 Diabetes MellitisUnited States
-
Dasman Diabetes InstituteRecruitingType 1 Diabetes (T1D) | Type 1 Diabetes Mellitus (T1DM)Kuwait
-
Superior UniversityActive, not recruitingType 2 Diabetes Mellitus 1Pakistan
-
Insulet CorporationNot yet recruitingType 1 Diabetes | Type 1 Diabetes Mellitus | Diabetes (DM)New Zealand
-
Poznan University of Medical SciencesUnknownDiabetes Mellitus Type 1 | Remission of Type 1 Diabetes | Chronic Complications of DiabetesPoland
Clinical Trials on Fit Families plus Standard Medical Care
-
Université de SherbrookeFerring Pharmaceuticals; Centre de recherche du Centre hospitalier universitaire...Active, not recruitingObesity | Infertility, FemaleCanada
-
Palmer College of ChiropracticUniversity of Iowa; Thomas Jefferson University; Health Resources and Services... and other collaboratorsCompleted
-
IWK Health CentreCanadian Institutes of Health Research (CIHR)CompletedAttention Deficit/Hyperactivity DisorderCanada
-
Jubaan Ltd.RecruitingMicrobiome | CRC ScreeningUnited States
-
Henry M. Jackson Foundation for the Advancement...U.S. Army Medical Research and Development CommandTerminatedCombat Disorders | Stress Disorders | Traumatic Stress DisordersUnited States
-
Avita MedicalNAMSACompletedVenous Leg UlcersUnited Kingdom, France
-
Cishan Hospital, Ministry of Health and WelfareCompletedFrailty | Sarcopenia | Long Term Care FacilityTaiwan
-
Queen Mary University of LondonCompleted
-
University of Missouri-ColumbiaCompletedLow Back Pain | Pelvic Pain | Adhesions | Scar TissueUnited States
-
University Hospital, MontpellierCompletedPrimary Lymphedema Secondary LymphedemaFrance